WCAS Completes Quest Diagnostics Sale

Welsh, Carson, Anderson & Stowe has completed its sale of diagnostics testing company Ameripath to Quest Diagnostics (NYSE: DGX). The deal was valued at approximately $2 billion, including $770 million in debt. WCAS acquired Ameripath in 2003 for approximately $840 million. www.ameripath.com